Vanda Pharmaceuticals VNDA
NASDAQ VNDA
$4.63 -0.18 (-3.74%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vanda Pharmaceuticals (VNDA) Shares Outstanding (Diluted) (2010 - 2026)

Updated

Vanda Pharmaceuticals (VNDA) reported Shares Outstanding (Diluted) of 60.23 million for Q2 2026, up 2.1% from 58.99 million a year earlier and up 1.3% from the prior quarter.

Analysis

Vanda Pharmaceuticals (VNDA) Shares Outstanding (Diluted) (2010 - 2026) Analysis & Trends

For FY2025, Vanda Pharmaceuticals posted Shares Outstanding (Diluted) of 58.93 million, up 1.3% from FY2024.

  • Shares Outstanding (Diluted) has increased for 14 consecutive years, with a five-year compound annual growth rate of 1.3% (FY2020 to FY2025).
  • By year, Shares Outstanding (Diluted) came in at 58.15 million in FY2024 (+1.0%), 57.56 million in FY2023 (+1.0%), 56.98 million in FY2022 (+0.1%) and 56.92 million in FY2021 (+3.1%).
  • The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2010.
  • Year over year, Shares Outstanding (Diluted) has now increased in each of the last 15 quarters, with growth averaging 1.4% over the last eight quarters.
  • The high point for year-over-year Shares Outstanding (Diluted) in five years was Q3 2021 (growth of 3.3%); the low point was Q1 2022 (a decline of 0.7%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 59.46 million (Q1 2026), 58.93 million (Q4 2025) and 59.09 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 893.70 Mn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.44 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.77 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.47 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 1.56 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 544.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.24 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 5.70 Bn
10 Vanda Pharmaceuticals 279.91 Mn -650.03 Mn 46.97 Mn 60.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 60.23 Mn
Mar 31, 2026 59.46 Mn
Dec 31, 2025 58.93 Mn
Sep 30, 2025 59.09 Mn
Jun 30, 2025 58.99 Mn
Mar 31, 2025 58.53 Mn
Dec 31, 2024 58.15 Mn
Sep 30, 2024 58.26 Mn
Jun 30, 2024 58.22 Mn
Mar 31, 2024 57.76 Mn
Dec 31, 2023 57.56 Mn
Sep 30, 2023 57.60 Mn
Jun 30, 2023 57.54 Mn
Mar 31, 2023 57.40 Mn
Dec 31, 2022 56.98 Mn
Sep 30, 2022 56.97 Mn
Jun 30, 2022 56.82 Mn
Mar 31, 2022 56.11 Mn
Dec 31, 2021 56.92 Mn
Sep 30, 2021 57.04 Mn
API Access

Vanda Pharmaceuticals Shares Outstanding (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=VNDA&period=max&api_key=YOUR_API_KEY